Alimera Sciences Anno IPO
Cos'è Anno IPO di Alimera Sciences?
Anno IPO di Alimera Sciences Inc. è 2010
Qual è la definizione di Anno IPO?
L'offerta pubblica iniziale è un tipo di offerta pubblica in cui le azioni di una società di solito sono vendute a investitori istituzionali che, a loro volta, vendono al pubblico in generale, su una borsa valori, per la prima volta.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Anno IPO di aziende nel Health Care settore su NASDAQ rispetto a Alimera Sciences
Cosa fa Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Aziende con anno ipo simili a Alimera Sciences
- Chigo ha Anno IPO di 2009
- Jade Road Investments ha Anno IPO di 2009
- Equity Metals ha Anno IPO di 2009
- Kerr Mines ha Anno IPO di 2009
- China e-Wallet Payment ha Anno IPO di 2009
- SQS India BFSI ha Anno IPO di 2009
- Alimera Sciences ha Anno IPO di 2010
- Broken Hill Prospecting ha Anno IPO di 2011
- Apollo Global Management Inc ha Anno IPO di 2011
- Hipo Resources ha Anno IPO di 2011
- Cogra 48 SA ha Anno IPO di 2011
- New Mountain Finance Corp ha Anno IPO di 2011
- Marfrig Global Foods SA ha Anno IPO di 2011